Trending: Payers increase focus on social determinants of health

Artificial Intelligence Medication Adherence Payers Thought Leadership

Improved understanding about the effect of social determinants of health (SDOH) on population health outcomes have spurred increased innovation from payers. Social determinants of health are the conditions where patients live, learn, work and play. Key SDOH areas include employment, education, crime and incarceration, access to healthcare, pollution, and food insecurity.

Addressing social determinants of health to improve chronic conditions

Humana’s 5 year old Bold Goal program has resulted in improvements in Healthy Days, a Centers for Disease Control and Prevention (CDC) metric. Humana’s program tackles needs such as food insecurity and social isolation to increase the number of Healthy Days for five chronic conditions: chronic obstructive pulmonary disease (COPD), coronary artery disease (CAD), depression, congestive heart failure (CHF), and hypertension.

Each of these conditions saw a decline in “Unhealthy Days” in 2019, ranging from 1.2 percent fewer Unhealthy Days for members with COPD to 3.2 percent fewer Unhealthy Days for members with hypertension.

Data drives SDOH program strategy

In addition, Humana performed 2.6 million screenings in 2019 to identify members who struggle with SDOH conditions. These millions of screening responses contributed to a more robust data set, which was pivotal in advancing the company’s strategy going forward.

“We’ve used a lot of that data to create advanced analytics, like predictive models and natural language processors,” said Andrew Renda, associate vice president of population health at Humana. “That really informs our strategy because it helps us understand number one, what the needs are, but also, how do we prioritize outreach to address needs and those people? So, analytics and data have been really important.”

Why access to SDOH data is not enough

It’s not enough to have access to SDOH data — you also need a team that understands the unique complexity of healthcare data. AllazoHealth’s sole focus is utilizing artificial intelligence to make a positive impact on healthcare outcomes. Our programs with payers include gap in care, adherence, and quality measures.

And AllazoHealth is the only healthcare AI adherence company to have run a randomized control trial. Partnering with Blue Cross Blue Shield of North Carolina, we demonstrated a 5.5 times uplift in adherence compared with traditional programs.

New call-to-action